Cancer Death Rates Vary Across Congressional Districts
Cancer death rates in the US have declined in recent years, but the declines vary by congressional district, a study suggests.
Diagnosis & Disease Information
Enzalutamide Ups Metastasis-Free Survival in nmHSPC
Investigators report results from the phase 3 randomized EMBARK trial.
Transgender Women May Be Underdiagnosed With Prostate Cancer
Findings suggest link to more aggressive disease among estrogen users, but researchers say larger studies needed.
Prostate Cancer Hits Patients With Substantial Out-of-Pocket Expenses
Investigators analyzed survey results from 495 patients with newly diagnosed localized prostate cancer.
Black Men With Metastatic Prostate Cancer More Frequently Refuse Chemotherapy
A recent study found a racial disparity in the use of guideline-concordant treatment for metastatic prostate cancer.
Radical Treatments May Not Decrease Prostate Cancer-Specific Mortality
Patients with localized prostate cancer have similar cancer-specific mortality whether they undergo surveillance, surgery, or radiotherapy, a study suggests.
Camonsertib-PARP Inhibitor Combos May Meet Unmet Need in Advanced Solid Tumors
Combining camonsertib with PARP inhibitors may be an effective strategy for treating advanced solid tumors, a study suggests.
Newly Identified Prostate Cancer Subtypes May Respond Differently to Treatment
Researchers say they have identified 4 subtypes of prostate cancer with distinct biological and clinical features, and these subtypes may respond differently to treatment.
Western Diet May Have Detrimental Effect on Prostate Cancer Risk
Stronger diet effect seen in Gleason grade group >6 and in International Society of Urological Pathology grade 3 + 4 + 5 tumors.
Metastasis-Directed Therapy Improves PFS in Oligometastatic Prostate Cancer
Adding MDT to intermittent hormone therapy improves disease control in oligometastatic prostate cancer, a phase 2 trial suggests.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...